Navigation Links
Sigma® Life Science Awarded Silver in Top Ten Innovations 2010
Date:12/2/2010

genetically modified reporter cell lines, as well as specific isogenic lines initially designed to advance colorectal and breast cancer research. The first CompoZr cellular reporter cell lines were launched in November 2010, and have been optimized for live cell imaging applications. Incorporating fluorescent tags at endogenous loci of the genes of interest, these new offerings avoid the additional stresses and potential toxicity issues associated with protein overexpression in live cells, as well as eliminating the need for tedious staining procedures.

For more information about Sigma Life Science's cell line products, visit http://www.wherebiobegins.com/biocells.

Cautionary statement: The foregoing release contains forward-looking statements that can be identified by terminology such as "underscores the potential," "rapidly been recognized," "our commitment," "designed to advance" or similar expressions, or by expressed or implied discussions regarding potential future revenues from products derived therefrom. You should not place undue reliance on these statements. Such forward-looking statements reflect the current views of management regarding future events, and involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. There can be no guarantee that CompoZr cell lines will achieve any particular levels of revenue in the future. In particular, management's expectations regarding CompoZr cell lines could be affected by, among other things, unexpected regulatory actions or delays or government regulation generally; the Company's ability to obtain or maintain patent or other proprietary intellectual property protection; competition in general; government, industry and general public pricing pressures; the impact that the foregoing facto
'/>"/>

SOURCE Sigma-Aldrich
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Sigma® Life Science Enters Genetically Modified Cell Market
2. The Pittsburgh Life Sciences Greenhouse Announces New Chairman of the Board
3. BioSpace Highlights the Northwests Growing Life Science Region
4. YM BioSciences Expands Phase I/II Trial for JAK Inhibitor CYT387
5. Call for Applications: The Amgen Award for Science Teaching Excellence
6. Elsevier Announces the SciVerse ScienceDirect eBooks Collection 2011 Frontlist
7. Ardea Biosciences to Present at Two Upcoming Investor Conferences
8. Elsevier Releases Image Search; New SciVerse ScienceDirect Feature Enables Researchers to Quickly Find Reliable Visual Content
9. YM BioSciences Reports Fiscal First Quarter 2011 Operational and Financial Results
10. Stallergenes Welcomes Ares Life Sciences as a New Reference Shareholder
11. Ben-Gurion University nano researcher to receive prestigious award for laser science and quantum physics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... , July 11, 2014 Research and ... Transfection Technology Market - Global Industry Analysis, Size, Share, ... their offering. http://photos.prnewswire.com/prnh/20130307/600769 ... nucleic acids (either DNA or RNA) into cells. This ... of cancer cells and protein metabolism by affecting the ...
(Date:7/11/2014)... 11, 2014  Researchers have pioneered a revolutionary ... new technology, called Virtual Finger, allows scientists to ... neurons and synapses using the flat surface of ... 3D imaging studies orders of magnitude more efficient, ... level across many areas of experimental biology. The ...
(Date:7/10/2014)... London, UK (PRWEB) July 10, 2014 ... inaugural 21st Century Medicine Forum on ‘Commercialising Longevity ... scientists and entrepreneurs to the London Bioscience Innovation ... Biogerontology Research Foundation and Aging Analytics Ltd. The ... and investment in translational research for age-related disease, ...
(Date:7/10/2014)... Robert Harman, DVM, Founder and CEO of Vet-Stem, ... announce the relaunch of his highly informative blog, now named ... “ What are Stem Cells ?” Dr. Harman’s purpose ... in the basics of stem cell therapy so that pet ... of treatment when considering regenerative medicine. , A veterinarian by ...
Breaking Biology Technology:International Transfection Technology Market - Industry Analysis, Size, Share, Growth, Trends and Forecast to 2019 2Virtual Finger Enables Scientists To Navigate And Analyze 3D Images Of Complex Biological Structures 2Virtual Finger Enables Scientists To Navigate And Analyze 3D Images Of Complex Biological Structures 3DKV Sponsors Forum on Commercialising Longevity Research; Brings Together Scientists, Investors, Entrepreneurs and Celebrities 2DKV Sponsors Forum on Commercialising Longevity Research; Brings Together Scientists, Investors, Entrepreneurs and Celebrities 3DKV Sponsors Forum on Commercialising Longevity Research; Brings Together Scientists, Investors, Entrepreneurs and Celebrities 4DKV Sponsors Forum on Commercialising Longevity Research; Brings Together Scientists, Investors, Entrepreneurs and Celebrities 5DKV Sponsors Forum on Commercialising Longevity Research; Brings Together Scientists, Investors, Entrepreneurs and Celebrities 6Robert Harman, DVM Talks About What Stem Cells are in His Latest Blog Series for Vet-Stem, Inc. 2Robert Harman, DVM Talks About What Stem Cells are in His Latest Blog Series for Vet-Stem, Inc. 3
... production, announced today the appointment of Michael Bayer, MD, as Director, ... and clinical trial protocols for use by research centers conducting pre-clinical ... ... Diego, CA (PRWEB) January 30, 2009 -- Stemedica Cell Technologies ...
... of future electronic devices could shrink dramatically to one ... many tens of nanometers that characterize today,s most advanced elements ... walls, the ultrathin transition zones that separate regions of a ... , In a material called bismuth ferrite, an unusual compound ...
... this inaugural edition of the BBVA Foundation Frontiers of ... (Austria, 1952) and Ignacio Cirac (Manresa, 1965), "for their ... of the jury chaired by Theodor W. Hnsch, Nobel ... up vital new avenues for the development of quantum ...
Cached Biology Technology:Stemedica Announces the Appointment of Dr. Michael Bayer as Director, Medical Services 2Stemedica Announces the Appointment of Dr. Michael Bayer as Director, Medical Services 3Domain walls that conduct electricity 2Domain walls that conduct electricity 3Domain walls that conduct electricity 4Domain walls that conduct electricity 5Peter Zoller and Ignacio Cirac, awarded by the BBVA Foundation 2
(Date:7/11/2014)... spider toxins to study the proteins that let nerve ... they have stumbled upon a biological tactic that may ... plagues in a safe and environmentally responsible way. ... lethal for one species and harmless for a closely ... specific pests without harming beneficial species like bees. A ...
(Date:7/10/2014)... , June 27, 2014  Pomerantz LLP ... Biopharmaceuticals, Inc. ("Provectus" or the "Company")(NYSE-MKT: PVCT) and ... in United States District Court, Middle District of ... on behalf of a class consisting of all ... Provectus securities between December 17, 2013 and May ...
(Date:7/10/2014)... 2014 It is a great honor for ... of the world-renowned Thoracic and Cardiovascular surgeon, Mark E ... Dr. Ginsburg, with over 34 years of experience, is ... Good Samaritan Regional Medical Center. Dr. Ginsburg has been ... and is considered an expert in the implantation of ...
Breaking Biology News(10 mins):Potent spider toxin 'electrocutes' German, not American, cockroaches 2Potent spider toxin 'electrocutes' German, not American, cockroaches 3SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Provectus Biopharmaceuticals, Inc. and Certain Officers - PVCT 2SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Provectus Biopharmaceuticals, Inc. and Certain Officers - PVCT 3Avery Biomedical Devices, Inc. announces the appointment of Mark E Ginsburg, M.D. to its Board of Directors 2
... the blinding effects of diabetic retinopathy is pointing toward ... said. Interleukin-6, known to contribute to the ... inflammation of the retina, a first step in a ... working-age adults, MCG researchers reported online in Investigative ...
... Since the time of the earliest humans, people have ... our surroundings and searched for explanations for natural phenomena. ... questions remain to be answered. Although we understand core ... understanding of issues such as how plants maximize their photosynthetic ...
... SCOTTSDALE, Ariz. Jan. 13, 2010 Researchers ... have identified a way to predict which patients with ... The study, Tumor MicroRNA Biomarkers Associated with De ... presented today in San Diego at a joint conference ...
Cached Biology News:Discovery points toward anti-inflammation treatment for blinding disease 2Seeing the forest through the trees and seeing the trees through the leaves 2TGen-Scottsdale Healthcare researchers make breakthrough in lung cancer 2
Recombinant DNA polymerase from Thermus aquaticus expressed in E. coli; 5 units/L; 1 tube of 1, 000 units enzyme/tube w/Buffer II and MgCl2...
Recombinant DNA polymerase from Thermus aquaticus expressed in E. coli; 5 units/uL; 25 tubes of 1, 000 units enzyme/tube w/ Buffer I...
A robust formulation of Taq Polymerase supplied with a 10X colored reaction buffer which allows Direct Gel-Loading...
Ps-Aeruginosa (IgA) -Ab EIA Sample Size: 100 l...
Biology Products: